Cadonilimab Plus Chemo Retains Clinically Meaningful Survival Advantage in Frontline Gastric/GEJ Adenocarcinoma

OncLive·Oct 23

This story is reported by OncLive. Read what other outlets are saying below, then open the original report for full details.